MX9602955A - Procedimiento para solubizar activos farmaceuticos dificilmente solubles. - Google Patents

Procedimiento para solubizar activos farmaceuticos dificilmente solubles.

Info

Publication number
MX9602955A
MX9602955A MX9602955A MX9602955A MX9602955A MX 9602955 A MX9602955 A MX 9602955A MX 9602955 A MX9602955 A MX 9602955A MX 9602955 A MX9602955 A MX 9602955A MX 9602955 A MX9602955 A MX 9602955A
Authority
MX
Mexico
Prior art keywords
soluble pharmaceutical
pharmaceutical actives
difficultly soluble
solubilizing
solubilizing difficultly
Prior art date
Application number
MX9602955A
Other languages
English (en)
Inventor
Dadi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX9602955A publication Critical patent/MX9602955A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un procedimiento para mejorar la solubilidad de activos farmacéuticos difícilmente solubles en una mezcla de polietilenglicol y propilenglicol utilizando una polivinilpirrolidona con un peso molecular promedio de viscosidad específico desde aproximadamente 5,000 hasta aproximadamente 25,000.
MX9602955A 1994-01-24 1995-01-24 Procedimiento para solubizar activos farmaceuticos dificilmente solubles. MX9602955A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (1)

Publication Number Publication Date
MX9602955A true MX9602955A (es) 1997-06-28

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9602955A MX9602955A (es) 1994-01-24 1995-01-24 Procedimiento para solubizar activos farmaceuticos dificilmente solubles.

Country Status (14)

Country Link
EP (1) EP0741560A1 (es)
JP (1) JPH09508128A (es)
CN (1) CN1138827A (es)
AU (1) AU706890B2 (es)
BR (1) BR9506564A (es)
CA (1) CA2181241C (es)
CZ (1) CZ210496A3 (es)
FI (1) FI962948A0 (es)
MX (1) MX9602955A (es)
NO (1) NO963052L (es)
NZ (1) NZ279443A (es)
PL (1) PL315635A1 (es)
SK (1) SK96196A3 (es)
WO (1) WO1995019759A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
ATE429210T1 (de) 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (fr) * 1999-07-29 2003-05-09 So Ge Val Sa Composition antipyretique concentree et stabilisee a usage veterinaire destine a etre incorporee a l'alimentation des animaux ainsi que procede d'incorporation de cette composition a l'eau de boisson d'animaux
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (de) * 2000-03-07 2001-09-13 Bayer Ag Acetylsalicylsäure-Lösungen
KR20020069387A (ko) * 2001-02-26 2002-09-04 진양제약주식회사 호박산독실아민 조성물 및 이 조성물을 함유한 연질캅셀제제
WO2003011306A1 (en) * 2001-07-31 2003-02-13 Wyeth Sucralose formulations to mask unpleasant tastes
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (zh) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 一种难溶性药物微丸的制备方法及包含该微丸的制剂
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
DE102005053066A1 (de) 2005-11-04 2007-05-10 Basf Ag Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
US20080300320A1 (en) * 2005-12-09 2008-12-04 Basf Se Use of Polyvinyl Lactam-Polyalkylene Block Copolymers as Solubilisers for Poorly Water-Soluble Compounds
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (ja) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd ソフトカプセル
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
PL2528602T5 (pl) 2010-01-28 2020-09-07 Eagle Pharmaceuticals, Inc. Preparaty bendamustyny
JP6250628B2 (ja) 2012-03-20 2017-12-20 イーグル・ファーマシューティカルズ・インコーポレーテッド ベンダムスチンの製剤
EP4218756A1 (en) 2012-03-20 2023-08-02 Eagle Pharmaceuticals, Inc. Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
CN108187054B (zh) * 2013-02-28 2021-07-13 Pf消费者保健第一有限责任公司 新液体组合物的增强的稳定性
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (zh) 2015-06-29 2017-06-11 永信藥品工業股份有限公司 一種製作難溶藥物固體劑型的方法
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
EP0741560A1 (en) 1996-11-13
CZ210496A3 (en) 1996-12-11
FI962948A (fi) 1996-07-23
BR9506564A (pt) 1997-09-02
SK96196A3 (en) 1997-03-05
CN1138827A (zh) 1996-12-25
CA2181241A1 (en) 1995-07-27
NO963052L (no) 1996-09-24
CA2181241C (en) 2000-04-25
PL315635A1 (en) 1996-11-25
JPH09508128A (ja) 1997-08-19
FI962948A0 (fi) 1996-07-23
NZ279443A (en) 1998-04-27
AU706890B2 (en) 1999-07-01
AU1607595A (en) 1995-08-08
WO1995019759A1 (en) 1995-07-27
NO963052D0 (no) 1996-07-22

Similar Documents

Publication Publication Date Title
MX9602955A (es) Procedimiento para solubizar activos farmaceuticos dificilmente solubles.
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
HUP9602122A3 (en) Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
GB9500116D0 (en) Pharmaceutical compositions
EP0647133A4 (en) COMPOSITIONS AND METHODS FOR IMPROVED DRUG DELIVERY.
IL115790A0 (en) Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof
MY125921A (en) Compositions containing organic compounds
IL108873A0 (en) 2-debenzoyl-2-acyl taxol derivatives, pharmaceutical compositions containing the same, and methods for the preparation thereof
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
PL340890A1 (en) Adamantane derivatives
HUP9700574A3 (en) N,n-dimethyl-(3-aryl-but-3-ene)-amine derivatives, pharmaceutical compositions containing them and process for the preparation thereof
CA2176713A1 (en) Amphiphilic Imidazolinium Derivatives
HUT61554A (en) Process for producing 2,8-dioxabicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same
DE69620761D1 (de) Pharmazeutisches praeparat auf der basis eines diclofenac-salzes und der verbindung thiocolchicosid
HU9301990D0 (en) Method for producing inclusion compounds of 5,10-methylene-tetrahydro-folic acid with cyclodextrin
ATE237610T1 (de) Substituierte dimere carboxamid-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
HUP9900987A3 (en) Camptothecin derivatives process for their preparation, use thereof as antitumor agents and pharmaceutical compositions containing them
HU9403383D0 (en) Diamine salts of clavulanic acid
HUP9701660A3 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, and pharmaceutical compositions containing them
EP0670166A3 (en) Pharmaceutical compositions for oral administration.
CA2089853A1 (fr) Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses
EP0380989A3 (en) Plaster for transdermal administration
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
BG103196A (en) Crystalline pharmaceutical product